Uses of pyrimidopyrimidinones as SIK inhibitors Grant US-11878019-B2 United States of America 23 Jan 2024
Bicyclic urea kinase inhibitors and uses thereof Grant US-11725011-B2 United States of America 15 Aug 2023
Uses of pyrimidopyrimidinones as SIK inhibitors Grant US-11285158-B2 United States of America 29 Mar 2022
Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis Grant US-11241435-B2 United States of America 08 Feb 2022
Bicyclic urea kinase inhibitors and uses thereof Grant US-10954242-B2 United States of America 23 Mar 2021
Uses of salt-inducible kinase (SIK) inhibitors Grant US-10265321-B2 United States of America 23 Apr 2019
SIK inhibitor for use in a method of treating an inflammatory and/or immune disorder Grant US-10233157-B2 United States of America 19 Mar 2019
Bacterial phospholipase inhibitors as modulator of colonic bacterial flora Grant US-10155041-B2 United States of America 18 Dec 2018
BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR… Application WO-2016141108-A1 World Intellectual Property Organisation (WIPO) 09 Sep 2016
BACTERIAL PHOSPHOLIPASE INHIBITORS AS MODULATOR OF COLONIC BACTERIAL FLORA Application WO-2015144737-A1 World Intellectual Property Organisation (WIPO) 01 Oct 2015
Bacterial phospholipase inhibitors as modulator of colonic bacterial flora Application EP-2923710-A1 European Patent Office 30 Sep 2015
USE OF A LIVE BACTERIUM FOR THE TREATMENT OF INTESTINAL INFLAMMATORY DISORDERS Application WO-2013190106-A1 World Intellectual Property Organisation (WIPO) 27 Dec 2013
A SIK INHIBITOR FOR USE IN A METHOD OF TREATING AN INFLAMMATORY AND/OR IMMUNE DISORDER Application WO-2013136070-A1 World Intellectual Property Organisation (WIPO) 19 Sep 2013